Earnings Call · Q3 FY2021·2021-11-04

Q3 21EPS +7.69%·Rev n/aQ2 21EPS +30.88%·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -10.53%·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

John Menditto — Investor Relations or similar management role

David Mazzo — President and Chief Executive Officer

James Nisco — Chief Financial Officer or similar financial role

Kristen Buck — Executive (likely Executive Vice President or similar)

−3.4%1d on move date−3.8% vs SPY3d−6.0%5d−10.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access